{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:16:17Z","timestamp":1771254977478,"version":"3.50.1"},"reference-count":25,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Victor Babes University of Medicine and Pharmacy Timisoara, Romania","award":["12921\/24.09.2020"],"award-info":[{"award-number":["12921\/24.09.2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Direct-acting antiviral (DAA) therapy has transformed chronic hepatitis C virus (HCV) infection into a curable disease. Beyond viral eradication, increasing attention has been directed toward metabolic changes following sustained virological response (SVR), particularly alterations in lipid metabolism. This study aimed to assess the long-term evolution of lipid parameters after HCV cure in a real-world clinical cohort. Methods: We conducted a prospective, single-center observational study including 85 patients with chronic HCV infection who achieved SVR after DAA therapy. Lipid parameters, including total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides, were assessed at baseline and during post-SVR follow-up at 24, 48, and 96 weeks. Body mass index (BMI) and non-invasive fibrosis indices were also evaluated. Longitudinal changes were analyzed using mixed-effects models. Results: Total cholesterol increased from 157.7 \u00b1 35.6 mg\/dL at baseline to 179.6 \u00b1 42.9 mg\/dL at SVR 24 and further to 189.0 \u00b1 40.3 mg\/dL at SVR 48, stabilizing at 177.7 \u00b1 38.3 mg\/dL at SVR 96. LDL-C showed a similar trajectory from 94.6 \u00b1 30.8 mg\/dL at baseline to 107.5 \u00b1 33.3 mg\/dL at SVR 24, further raising to 115.7 \u00b1 36.2 mg\/dL at SVR48, and 111.8 \u00b1 39.5 mg\/dL at SVR 96. HDL-C showed minimal change, while triglycerides demonstrated greater interindividual variability without a consistent population-level trend. BMI remained stable over follow-up (26.6 \u00b1 4.7 to 27.6 kg\/m2). Linear mixed-effects models confirmed a significant effect of time after SVR on total cholesterol and LDL-C (p &lt; 0.05). Conclusions: In this real-world cohort, HCV cure with DAA therapy was associated with sustained long-term changes in lipid metabolism, characterized by increases in total cholesterol and LDL-C independent of major weight changes. These findings support the importance of continued metabolic monitoring after SVR, particularly in patients with additional cardiometabolic risk factors.<\/jats:p>","DOI":"10.3390\/healthcare14040486","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:09:54Z","timestamp":1771250994000},"page":"486","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal Changes in Lipid Profile After Sustained Virological Response in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3626-9857","authenticated-orcid":false,"given":"Oana","family":"Koppandi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Western University \u201cVasile Goldis\u201d of Arad, Revolutiei Boulevard 94, 310025 Arad, Romania"},{"name":"Multidisciplinary Doctoral School, Western University \u201cVasile Goldis\u201d of Arad, Revolutiei Boulevard 94, 310025 Arad, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5336-5789","authenticated-orcid":false,"given":"Bogdan","family":"Miutescu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Advanced Regional Research Center in Gastroenterology and Hepatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-9926","authenticated-orcid":false,"given":"Iulia","family":"Ratiu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Advanced Regional Research Center in Gastroenterology and Hepatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-4087","authenticated-orcid":false,"given":"Alexandru","family":"Popa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Advanced Regional Research Center in Gastroenterology and Hepatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Nica","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Advanced Regional Research Center in Gastroenterology and Hepatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5087-1611","authenticated-orcid":false,"given":"Eyad","family":"Gadour","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Abdulaziz Hospital-National Guard, Ahsa 31982, Saudi Arabia"},{"name":"Department of Internal Medicine, Faculty of Medicine, Zamzam University College, Khartoum 11113, Sudan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan Dan","family":"Totolici","sequence":"additional","affiliation":[{"name":"Multidisciplinary Doctoral School, Western University \u201cVasile Goldis\u201d of Arad, Revolutiei Boulevard 94, 310025 Arad, Romania"},{"name":"Department of Surgery, Faculty of Medicine, Western University \u201cVasile Goldis\u201d of Arad, Revolutiei Boulevard 94, 310025 Arad, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7405-4779","authenticated-orcid":false,"given":"Raluca","family":"Lupusoru","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Department III, Functional Science, Discipline of Medical Informatics and Biostatistics, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Center for Modeling Biological Systems and Data Analysis, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Ghiuchici","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Advanced Regional Research Center in Gastroenterology and Hepatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eftimie","family":"Miutescu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Western University \u201cVasile Goldis\u201d of Arad, Revolutiei Boulevard 94, 310025 Arad, Romania"},{"name":"Multidisciplinary Doctoral School, Western University \u201cVasile Goldis\u201d of Arad, Revolutiei Boulevard 94, 310025 Arad, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2026, January 06). Hepatitis C. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jvh.13679","article-title":"Efficacy and safety of direct-acting antiviral therapy for hepatitis C virus in elderly patients (\u226565 years old): A systematic review and meta-analysis","volume":"29","author":"Lee","year":"2022","journal-title":"J. Viral Hepat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/liv.14126","article-title":"Efficacy and safety of direct-acting antivirals for hepatitis C in the elderly: A systematic review and meta-analysis","volume":"39","author":"Herrmann","year":"2019","journal-title":"Liver Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/jgh.16892","article-title":"Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting Antivirals","volume":"40","author":"Ogawa","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1038\/s41598-021-93251-3","article-title":"Serum lipid profile in HCV patients treated with direct-acting antivirals: A systematic review and meta-analysis","volume":"11","author":"Villani","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Cavalletto, L., Bertoli, E., Mescoli, C., Aliberti, C., Quaranta, M.G., Kondili, L., and Chemello, L. (2025). Long-Term Risk of Hepatic and Extrahepatic-Related Events After Direct Antiviral Therapy for Chronic Hepatitis C: A Prospective Long-Term Study Cohort. Cancers, 17.","DOI":"10.3390\/cancers17091528"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Elgretli, W., Chen, T., Kronfli, N., and Sebastiani, G. (2023). Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020271"},{"key":"ref_8","first-page":"436","article-title":"Serum cholesterol and chronic hepatitis C","volume":"28","author":"Maggi","year":"1996","journal-title":"Ital. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Graf, C., Welzel, T., Bogdanou, D., Vermehren, J., Beckel, A., Bojunga, J., Friedrich-Rust, M., Dietz, J., Kubesch, A., and Mondorf, A. (2020). Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092702"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hashimoto, S., Yatsuhashi, H., Abiru, S., Yamasaki, K., Komori, A., Nagaoka, S., Saeki, A., Uchida, S., Bekki, S., and Kugiyama, Y. (2016). Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163644"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3851\/IMP3094","article-title":"Effect of Antiviral Therapy for HCV on Lipid Levels","volume":"22","author":"Mauss","year":"2017","journal-title":"Antivir. Ther."},{"key":"ref_12","first-page":"3175","article-title":"A Study of the Impact of Treatment Response to Direct Acting Antivirals on Serum Lipid Profile in Egyptian Patients with Chronic HCV Infection","volume":"87","author":"Abdelrahman","year":"2019","journal-title":"Med. J. Cairo Univ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12944-023-01957-2","article-title":"Effects of sustained viral response on lipid in Hepatitis C: A systematic review and meta-analysis","volume":"23","author":"Mei","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2019.10.005","article-title":"Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals","volume":"72","author":"Pons","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Trifan, A., Cuciureanu, T., Nastasa, R., Stratina, E., Zenovia, S., Muzica, C.M., Huiban, L., Singeap, A.M., Chiriac, S., and Sfarti, C. (2023). Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection. Life, 13.","DOI":"10.3390\/life13020534"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3350\/cmh.2025.0155","article-title":"Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on \u201cAdverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C\u201d","volume":"31","author":"Liu","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Estefan, S., Brand\u00e3o-Melo, C.E., dos Santos Silva, C.M., Gomes, D.C.K., Cardoso, P., and Costa, M.H.S. (2021). Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents. Front. Med., 8.","DOI":"10.3389\/fmed.2021.631600"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.3748\/wjg.v21.i36.10299","article-title":"Chronic hepatitis C virus infection and lipoprotein metabolism","volume":"21","author":"Aizawa","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.23219","article-title":"Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up","volume":"50","author":"Corey","year":"2009","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3748\/wjg.v27.i17.1959","article-title":"Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond","volume":"27","author":"Shengir","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4254\/wjh.v14.i6.1120","article-title":"Fibrosis regression following hepatitis C antiviral therapy","volume":"14","author":"Elsharkawy","year":"2022","journal-title":"World J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3350\/cmh.2024.0904","article-title":"Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C","volume":"31","author":"Ryu","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jhep.2024.04.007","article-title":"EASL position paper on clinical follow-up after HCV cure","volume":"81","author":"Reiberger","year":"2024","journal-title":"J. Hepatol."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/4\/486\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:33:14Z","timestamp":1771252394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/4\/486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["healthcare14040486"],"URL":"https:\/\/doi.org\/10.3390\/healthcare14040486","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]}}}